Rhodococcus

Pathogenesis of Bacterial Infections in Animals: Fourth Edition

Volumn , Issue , 2010, Pages 149-166

  Prescott, J F ^a   Meijer, W G ^b   Vazquez Boland J A ^c  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Ammonia inhibiting phagolysosome formation; Lack of vacuolar proton pump mildly acid conditions; Lipids of phagosome, membrane cholesterol carbon sources for intracellular pathogens; Mechanisms of T lymphocytes mediating clearance cytokines secretion, direct cytotoxicity; Mycolic acids survival of mycobacteria inside phagocyte; Phagosomal maturation progressive acidification; Rhodococcus; Rhodococcus equi causing pneumonia in foals

Indexed keywords

EID: 79952729520     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470958209.ch9     Document Type: Chapter

References (92)

1. Aderem, A., and D. M. Underhill. 1999. Mechanisms of phagocytosis in macrophages. Ann. Rev. Immunol. 17:593-623.
2. Barbey, C., A. Budin-Verneuil, S. Cauchard, A. Hartke, C. Laugier, V. Pichereua, et al. 2008. Proteomic analysis and immunogenicity of secreted proteins from Rhodococcus equi. Vet. Microbiol. 135:334-345.
3. Benoit, S., A. Benachour, S. Taouji, Y. Auffray, and A. Hartke. 2001. Induction of vap genes encoded by the virulence plasmid of Rhodococcus equi during acid tolerance response. Res. Microbiol. 152:439-449.
4. 2, which causes macrophage-related stress, triggers induction of expression of virulence-associated plasmid determinants in Rhodococcus equi. Infect. Immun. 70:3768-3776.
5. Bhatt, A., V. Molle, G. S. Besra, W. R. Jr. Jacobs, and L. Kremer. 2007. The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development. Mol. Microbiol. 64:1442-1454.
6. Boland, C. A., and W. G. Meijer. 2000. The iron dependent regulatory protein IdeR (DtxR) of Rhodococcus equi. FEMS Microbiol. Lett. 191:1-5.
7. Breathnach, C. C., T. Sturgill-Wright, J. L. Stiltner, A. A. Adams, D. P. Lunn, and D. W. Horohov. 2006. Foals are interferon gamma-deficient at birth. Vet. Immunol. Immunopathol. 112:199-209.
8. Briken, V., S. A. Porcelli, G. S. Besra, and L. Kremer. 2004. Mycobacterial liparabinomannam and related lipglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53:391-403.
9. Brzostek, A., B. Dziadek, A. Rumijowska-Galewicz, J. Pawelczyk, and J. Dziadek. 2007. Cholesterol oxidase is required for virulence of Mycobacterium tuberculosis. FEMS Microbiol. Lett. 275:106-112.
10. Byrne, B. A., J. F. Prescott, G. H. Palmer, S. Takai, V. M. Nicholson, D. C. Alperin, et al. 2001. Virulence plasmid of Rhodococcus equi contains inducible gene family encoding secreted proteins. Infect. Immun. 69:650-656.
11. Byrne, G. A., C. A. Boland, E. P. O'Connell, and W. G. Meijer. 2008. Differential mRNA stability of the vapAICD operon of the facultative intracellular pathogen Rhodococcus equi. FEMS Microbiol. Lett. 280:89-94.
12. Byrne, G. A., D. A. Russell, X. Chen, and W. G. Meijer. 2007. Transcriptional regulation of the virR operon of the intracellular pathogen Rhodococcus equi. J. Bacteriol. 189:5082-5089.
13. Cellier, M. F., P. Courville, and C. Campion. 2007. Nramp1 phagocyte intracellular metal withdrawal defense. Microbes Infect. 9:1662-1670.
14. Colangeli, R., A. Haq, V. L. Arcus, E. Summers, R. S. Magliozzo, A. McBride, et al. 2009. The multifunctional histone-like protein Lsr2 protects mycobacteria against reactive oxygen intermediates. Proc. Natl. Acad. Sci. USA 106:4414-4418.
15. Darrah, P. A., M. K. Hondalus, Q. Chen, H. Ischiropoulos, and D. M. Mosser. 2000. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect. Immun. 68:3587-3593.
16. Fernandez-Mora, E., M. Polidori, A. Lührmann, U. E. Schaible, and A. Haas. 2005. Maturation of Rhodococcus equi-containing vacuoles is arrested after completion of the early endosome stage. Traffic. 6:635-653.
17. Flaminio, M. J., D. V. Nydam, H. Marguis, M. B. Matychak, and S. Giguère. 2008. Foal monocyte-derived dendritic cells become activated upon Rhodococcus equi infection. Clin. Vaccine Immunol. Epub.
18. Garton, N. J., M. Gilleron, T. Brando, H-H. Dan, S. Giguère, G. Puzo, et al. 2002. A novel lipoarabino-mannam from the equine pathogen Rhodococcus equi: structure and effect on macrophage cytokine production. J. Biol. Chem. 277:31722-31733.
19. Giguère S., B. N. Wilkie, and J. F. Prescott. 1999. Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi. Infect. Immun. 67:5041-5047.
20. Gold, B., G. M. Rodriguez, S. A. Marras, M. Pentecost, and I. Smith. 2001. The Mycobacterium tuberculosis IdeR is a dual functional regulator that controls transcription of genes involved in iron acquisition, iron storage and survival in macrophages. Mol. Microbiol. 42:851-865.
21. Gotoh, K., M. Mitsuyama, S. Imaizumi, I. Kawamura, I. and I. Yano. 1991. Mycolic acid-containing glycolipid as a possible virulence factor of Rhodococcus equi for mice. Microbiol. Immunol. 35:175-185.
22. Halbert, N. D., N. D. Cohen, N. M. Slovis, J. Faircloth, and R. J. Martens. 2006. Variation in equid SLC11A1 (NRAMP1) genes and association with Rhodococcus equi pneumonia in horses. J. Vet. Intern. Med. 20:974-979.
23. Harrington, J. R., R. J. Martens, N. D. Cohen, and L. R. Bernstein. 2006. Antimicrobial activity of gallium against virulent Rhodococcus equi in vitro and in vivo. J. Vet. Pharmacol. Ther. 29:121-127.
24. Hines, M. T., K. M. Paasch, D. C. Alperin, G. H. Palmer, N. C. Westhoff, S. A. Hines. 2001. Immunity to Rhodococcus equi: antigen-specific recall responses in the lungs of adult horses. Vet. Immunol. Immunopathol. 79:101-113.
25. Hines, S. A., S. T. Kanaly, B. A. Byrne, and G. H. Palmer. 1997. Immunity to Rhodococcus equi. Vet. Microbiol. 56:177-185.
26. Hines, S. A., D. M. Stone, M. T. Hines, D. C. Alperin, D. P. Knowles, L. K. Norton, et al. 2003. Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4(+) and CD*(+) T lymphocytes. Clin. Diagn. Lab. Immunol. 10:208-215.
27. Hondalus, M. K. 1997. Pathogenesis and virulence of Rhodococcus equi. Vet. Microbiol. 56:257-268.
28. Hondalus, M. K., and D. M. Mosser. 1994. Survival and replication of Rhodococcus equi in macrophages. Infect. Immun. 62:4167-4175.
29. Hong, Y., and M. K. Hondalus. 2008. Site-specific integration of Streptomyces PhiC31 integrase-based vectors in the chromosome of Rhodococcus equi. FEMS Microbiol. Lett. 287:63-68.
30. Hooper-McGrevy, K. E., S. Giguère, B. N. Wilkie, and J. F. Prescott. 2001. Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia. Am. J. Vet. Res. 62:1307-1313.
31. Hooper-McGrevy, K. E., B. N. Wilkie, and J. F. Prescott. 2003. Immunoglobulin G sub-isotype response of pneumonic and healthy, exposed foals and adult horses to Rhodococcus equi virulence-associated proteins. Clin. Diagn. Lab. Immunol. 23:5760-5767.
32. Jacks, S., S. Giguère, P. C. Crawford, and W. L. Castleman. 2007a. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin. Vaccine Immunol. 14:669-677.
33. Jacks, S., S. Giguère, and J. F. Prescott. 2007b. In vivo expression of and cell-mediated immune responses to the plasmid-encoded virulence-associated proteins of Rhodococcus equi in foals. Clin. Vaccine Immunol. 14:369-374.
34. Jain, S., B. R. Bloom, and M. K. Hondalus. 2003. Deletion of vapA encoding virulence-associated protein A attenuates the intracellular actinomycete Rhodococcus equi. Mol. Microbiol. 50:115-128.
35. Jordan, M. C., J. R. Harrington, N. D. Cohen, R. M. Tsolis, L. J. Dangott, E. D. Weinberg, et al. 2003. Effects of iron modulation on growth and viability of Rhodococcus equi and expression of virulence-associated protein A. Am. J. Vet. Res. 64:1337-1346.
36. + Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect. Immun. 64:1126-1132.
37. Kelly, B. G., D. M. Wall, C. A. Boland, and W. G. Meijer. 2002. Isocitrate lyase of the facultative intracellular pathogen Rhodococcus equi. Microbiol. 148:793-798.
38. Kasuga-Aoki, H., S. Takai, Y. Sasaki, S. Tsubaki, H. Madarame, and A. Nakane. 1999. Tumour necrosis factor and interferon-gamma are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R. equi. Immunology. 96:122-127.
39. Letek, M., M. Blanco, A. Ocampo-Sosa, D. A. Lewis, N. Bason, I. Cherevach, et al. 2008a. The Rhodococcus equi genome. Proc. 4th Havemeyer Workshop on Rhodococcus equi, Edinburgh July 13-16, p. 17.
40. Letek, M., A. A. Ocampo-Sosa, M. Sanders, U. Fogarty, T. Buckley, D. P. Leadon, et al. 2008b. Evolution of the Rhodococcus equi pathogenicity island seen through comparison of host-adapted vapA and vapB virulence plasmids. J. Bacteriol. 190:5797-5805.
41. Liu, T., J. Nerren, M. Liu, R. Martens, and N. Cohen. 2008. Basal and stimulus-induced cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn foals. Vaccine 27:674-683.
42. Lopez, A. M., M. T. Hines, G. H. Palmer, D. C. Alperin, and S. A. Hines. 2002. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi. Clin. Diagn. Lab. Immunol. 9:1270-1276.
43. Lorenz, M. C., and G. R. Fink. 2001. The gloxylate cycle is required for fungal virulence. Nature 412:83-86.
44. Lührmann, A., N. Mauder, T. Sydor, E. Fernandez-Mora, J. Schulze-Luehrmann, S. Takai, et al. 2004. Necrotic death of Rhodococcus equi-infected macrophages is regulated by virulence-associated plasmids. Infect. Immun. 72:853-862.
45. Manabe, Y. C., B. J. Saviola, L. Sun, J. R. Murphy, and W. R. Bishai. 1999. Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressor. Proc. Natl. Acad. Sci. U S A 96:12844-12848.
46. Martens, R. J., K. Mealey, N. D. Cohen, J. R. Harrington, M. K. Chaffin, R. J. Taylor, et al. 2007b. Pharmacokinetics of gallium maltolate against intragastric administration in neonatal foals. Am. J. Vet. Res. 68:1041-1044.
47. Martens, R. J., N. A. Miller, N. D. Cohen, J. R. Harrington, and L. R. Bernstein. 2007a. Chemoprophylactic antimicrobial activity of gallium maltolate against intracellular Rhodococcus equi. J. Equine Vet. Sci. 27:341-345.
48. McKinney, J. D., K. Höner zu Bentrup, E. J. Munoz-Elias, A. Miczak, B. Chen, W. T. Chan, et al. 2000. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735-738.
49. Miranda-Casosluengo, R. P., S. Duffy, E. P. O'Connell, B. J. Graham, M. W. Mangan, J. F. Prescott, et al. 2005. The iron-regulated iupABC operon is required for saprophytic growth of the intracellular pathogen Rhodococcus equi at low iron concentrations. J. Bacteriol. 187:3438-3444.
50. Miranda-Casoluengo, R., J. F. Prescott, J. A. Vázquez-Boland, and W. G. Meijer. 2008. The intracellular pathogen Rhodococcus equi produces a catecholate siderophore required for saprophytic growth. J. Bacteriol. 190:1631-1637.
51. Mousel, M. R., L. Harrison, J. M. Donahue, and E. Bailey. 2003. Rhodococcus equi and genetic susceptibility: assessing transferring genotypes from paraffin-embedded tissues. J. Vet. Diagn. Invest. 15:470-472.
52. Muscatello, G., S. Gerbaud, C. Kennedy, J. R. Gilkerson, T. Buckley, M. Klay, et al. 2006. Comparison of concentrations of Rhodococcus equi and virulent R. equi in air of stables and paddocks on horse breeding farms in a temperate climate. Equine Vet. J. 38:263-265.
53. Muscatello, G., J. R. Gilkerson, and G. F. Browning. 2009. Detection of virulent Rhodococcus equi in exhaled air samples from naturally infected foals. J. Clin. Microbiol. 47:734-737.
54. Muscatello, G., D. P. Leadon, M. Klay, A. Ocampo-Sosa, D. A. Lewis, U. Fogarty, et al. (2007). Rhodococcus equi infection in foals: the science of "rattles." Equine Vet. J. 39:470-478.
55. Nordengrahn, A., M. Rusvai, M. Merza, J. Ekstrom, B. Morein, and S. Belak. 1996. Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunos-timulating complexes. Vet Microbiol. 51:55-68.
56. Nordmann, P., M. Keller, F. Espinasse, and E. J. Ronco. 1994. Correlation between antibiotic resistance, phage-like particle presence, and virulence in Rhodococcus equi human isolates. J. Clin. Microbiol. 32:377-383.
57. Ocampo-Sosa, A. A., D. A. Lewis, J. Navas, F. Quigley, R. Callejo, M. Scortti, et al. 2007. Molecular epidemiology of Rhodococcus equi based on traA, vapA, and vapB virulence plasmid markers. J. Infect. Dis. 196:763-769.
58. Pargass, I. S., T. B. Wills, W. C. Davis, K. J. Wardrop, D. C. Alperin, and S. A. Hines. 2009. The influence of age and Rhodococcus equi infection on CD1 expression by equine antigen presenting cells. Vet. Immunol. Immunopathol. Epub.
59. Patton, K. M., T. C. McGuire, D. G. Fraser, and S. A. Hines. 2004. Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lympocytes in a major histocompatibility complex class I-unrestricted manner. Infect. Immun. 72:7073-7083.
60. Patton, K. M., T. C. McGuire, M. T. Hines, R. H. Mealey, and S. A. Hines. 2005. Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals. Infect. Immun. 73:2083-2093.
61. Pei, Y.-L., C. Dupont, T. Sydor, A. Haas, and J. F. Prescott. 2006. Cholesterol oxidase (ChoE) is not important in virulence in Rhodococcus equi. Vet. Microbiol. 118:240-246.
62. Pei, Y.-L., V. Parreira, V. M. Nicholson, and J. F. Prescott. 2007a. Mutation and virulence assessment of chromosomal genes of Rhodococcus equi 103. Can. J. Vet. Res. 71:1-7.
63. Pei, Y.-L., V. M. Nicholson, K. Woods, and J. F. Prescott. 2007b. Immunization by intrabronchial administration to 1-week-old foals of an unmarked double gene disruption strain of Rhodococcus equi strain 103+. Vet. Microbiol. 125:100-110.
64. Power, C. A., G. Wei, and P. A. Bretscher. 1998. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intrademal route. Infect. Immun. 66:5743-5750.
65. Prescott, J. F., V. M. Nicholson, M. C. Patterson, M. C. Zandona Meleiro, A. Caterino de Araujo, et al. 1997. Use of Rhodococcus equi virulence-associated protein for immunization of foals against Rhodococcus equi pneumonia. Am. J. Vet. Res. 58:356-359.
66. Rahman, M. T., V. Parreira, and J. F. Prescott. 2005. In vitro and intra-macrophage gene expression by Rhodococcus equi strain 103. Vet. Microbiol. 110:131-140.
67. Pym, A. S., P. Domech, N. Honoré, J. Song, V. Deretic, and S. T. Cole. 2001. Regulation of catalase-peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis. Mol. Microbiol. 40:879-889.
68. Riess, F. G., M. Eflein, M. Benk, B. Schiffler, R. Benz, N. Garton, et al. 2003. The cell wall of the pathogenic bacterium Rhodococcus equi contains two channel-forming proteins with different propoerties. J. Bacteriol. 185:2952-2960.
69. Ren, J., and J. F. Prescott. 2003. Analysis of virulence plasmid gene expression of intramacrophage and in vitro grown Rhodococcus equi ATCC 33701. Vet. Microbiol. 94:167-182.
70. Ren, J., and J. F. Prescott. 2004. The effect of mutation on Rhodococcus equi virulence plasmid gene expression and mouse virulence. Vet. Microbiol. 103:219-230.
71. Russell, D. G. 2001. Mycobacterium tuberculosis: here today, and here tomorrow. Nature reviews. Mol. Cell. Biol. 2:569-577.
72. Russell, D. A., G. A. Byrne, E. P. O'Connell, C. A. Boland and W. G. Meijer. 2004. The LysR-type transcriptional regulator VirR is required for expression of the virulence gene vapA of Rhodo-coccus equi ATCC 33701. J. Bacteriol. 186:5576-5584.
73. Sponseller, B. A., M. M. de Macedo, S. K. Clark, J. M. Gallup, and D. E. Jones. 2008. Activation of peripheral blood monocytes results in more robust production of IL-10 in neonatal foals compared to adult horses. Vet. Immunol. Immunopathol. Epub.
74. Sutcliffe, I. C. 1998. Cell wall composition and organization in the genus Rhodococcus. Antonie Van Leewenhoek 74:49-58.
75. Sydor, T., K. von Bargen, U. Becken, S. Spuerck, V. M. Nicholson, J. F. Prescott, et al. 2008. A mycolyl transferase mutant of Rhodococcus equi lacking capsule integrity is fully virulent. Vet. Microbiol. 128:327-341.
76. Takai, S. 1997. Epidemiology of Rhodococcus equi infections: A review. Vet. Microbiol. 56:167-176.
77. Takai, S., N. Fukunaga, K. Kamisawa, Y. Imai, Y. Sasaki, and S. Tsubaki. 1996a. Expression of virulence-associated antigens of Rhodococcus equi is regulated by temperature and pH. Microbiol. Immunol. 40:591-594.
78. Takai, S., N. Fukunaga, S. Ochiai, Y. Imai, Y. Sasaki, S. Tsubaki, and T. Sekizaki. 1996b. Identification of intermediately virulent Rhodococcus equi from pigs. J. Clin. Microbiol. 34:1034-1037.
79. Takai, S., S. A., Hines, T. Sekizaki, V. M. Nicholson, D. Alperin, M. Osaki, et al. 2000. DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103. Infect. Immun. 68:6840-6847.
80. Takai, S., M. Iie, Y. Watanabe, S. Tsubaki, and T. Sekizaki. 1992. Virulence-associated 15-to 17-kilodalton antigens in Rhodococcus equi: temperature-dependent expression and location of the antigens. Infect. Immun. 60:2995-2997.
81. Takai, S., K. Koike, S. Ohbushi, C. Izumi, and S. Tsubaki. 1991a. Identification of 15-to 17-kilodal-ton antigens associated with virulent Rhodococcus equi. J. Clin. Microbiol. 29:439-443.
82. Takai, S., T. Sekizaki, T. Ohbushi, C. Izumi, T. Sungawara, Y. Watanabe, et al. 1991b. Association between a large plasmid and 15-to 17-kilodalton antigens in virulent Rhodococcus equi. Infect. Immun. 59:4056-4060.
83. Tan, C., J. F. Prescott, M. C. Patterson and V. M. Nicholson. 1995. Molecular characterization of a lipid-modified virulence-associated protein of Rhodococcus equi and its potential in protective immunity. Can. J. Vet. Res. 59:51-59.
84. Tjelle, T. E., T. Lovdal, and T. Berg. 2000. Phagosome dynamics and function. Bioessays 22:255-263.
85. Tkachuk-Saad, O., P. Lusis, R. D. Welch, and J. F. Prescott. 1998. Rhodococcus equi infection in goats. Vet. Rec. 143:311-312.
86. Tkachuk-Saad, O., and J. Prescott. 1991. Rhodococcus equi plasmid: isolation and partial characterization. J. Clin. Microbiol. 29:2696-2700.
87. Toyooka, K., S. Takai, and T. Kirikae. 2005. Rhodococcus equi can survive a phagolysosomal environment in macrophages by suppressing acidification of the phagolysosome. J. Med. Microbiol. 54:1007-1015.
88. Ueda, S., N. Fujuwara, T. Naka, I. Sakaguchi, Y. Ozeki, I. Yano, et al. 2001. Structure-activity relationship of mycolyl glycolipids derived from Rhodococcus sp. 4306. Microbial Pathogen. 30:91-99.
89. Van der Geize, R., W. de Jong, G. I. Hessels, A. A. Jacobs, and L. Dijhuizen. 2008. A novel method to generate unmarked gene deletions in the intracellular pathogen Rhodococcus equi using 5-fluorocy-tosine conditional lethality. Nucleic Acids Res 36 : e151.
90. Wall, D. M., P. S. Duffy, C. DuPont, J. F. Prescott, and W. G. Meijer. 2005. Isocitrate lyase activity is required for virulence of the intracellular pathogen Rhodococcus equi. Infect. Immun. 73:6736-6741.
91. Wassenaar, T. M., and W. Gaastra. 2001. Bacterial virulence: can we draw the line? FEMS Microbiol. Lett. 201:1-7.
92. Welin, A., M. E. Winberg, H. Abdalla, E. Sarndahl, B. Rasmusson, O. Stendahl, et al. 2008. Incorporation of Mycobacterium tuberculosis lipoarabinomannam into macrophage membrane rafts is a prerequisite of the phago-somal maturation block. Infect. Immun. 76:2882-2887.